Skip to main content
All lobbying filings

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Lobbying for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $201,227.00 income · posted Apr 15, 2025

Official filing document

 Bills named in this filing 1
 Lobbying activity 5
Health Issues

- Reauthorization of the Over the Counter Monograph User Fee Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - FDA Modernization Act 3.0

Pharmacy

- The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act

Consumer Issues/Safety/Products

- The SHOP SAFE Act

Taxation/Internal Revenue Code

- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)

Manufacturing

- Pharmaceutical Tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem